Delivery Order SPE2DB20D1051-SPE2DB25FD7AF

Award Date 2/14/25
Potential Completion Date 2/18/25
Potential Value $5.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,779.18, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of MULTAQ 400 MG TABLET 60S, a pharmaceutical product, with a completion date of September 9, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and...
This federal contract award, valued at $2,960.28, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of MULTAQ 400 MG TABLET 60S, a pharmaceutical product, with a completion date of December 13, 2024. The contract type is a Delivery Order with a Firm Fixed Price pricing structure, and there is no set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions...
This federal contract award, with ID SPE2DB22D2206|SPE2DB24FGA61, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $7,403.39 firm fixed-price delivery order is for the pharmaceutical product "MULTAQ 400 MG TABLET 60S". The contract has an ultimate completion date of March 12, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The $9,367.37 firm fixed price delivery order is for the pharmaceutical product MULTAQ 400 MG TABLET 60S. The contract has a completion date of December 17, 2024 and is not designated with a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,620.18, is a delivery order for the supply of MULTAQ 400 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of November 8, 2024 and was awarded on November 7, 2024. It is a firm fixed-price contract, with no set-aside designation....
This federal contract award, with ID SPE2DB24D1107|SPE2DB24FZEE6, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a delivery order valued at $19,040.18 and has a firm fixed price pricing type. It is for the supply of MULTAQ 400 MG TABLET 60S, a pharmaceutical product, with an ultimate completion date of May 2, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The $2,876.60 firm fixed price delivery order is for the pharmaceutical product MULTAQ 400 MG TABLET 60S. The contract has an ultimate completion date of October 7, 2024. Amerisourcebergen, a major pharmaceutical distributor and healthcare solutions provider, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,825.59 firm fixed-price delivery order is for the supply of MULTAQ 400 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of March 26, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,957.52 firm fixed-price delivery order is for the supply of MULTAQ 400 MG TABLET 60S, a prescription medication. The contract has an ultimate completion date of December 9, 2024 and is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen holds a significant $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The award, valued at $26,119.96, is for the delivery of MULTAQ 400 MG TABLET 60S, a pharmaceutical product, under a firm fixed-price contract. The contract has an ultimate completion date of May 17, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying...
  • SPE2DB20D1051
    Indefinite Delivery Contract
  • SPE2DB20D1051-SPE2DB25FD7AF
    Delivery Order

This federal contract award, with the ID SPE2DB20D1051|SPE2DB25FD7AF, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $5,173.26 firm fixed-price delivery order is for the pharmaceutical product MULTAQ 400 MG TABLET 60S. The contract has an ultimate completion date of February 18, 2025.

Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly within military and veterans' healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/16/25, 11:44 AM